Hives aren’t generally dangerous and often go away on their own. There are many other types of rashes with a wide variety of ...

A urticaria rash can either be a nonimmune response to ... risk factors, symptoms, and treatment. Contact urticaria is an immediate and short lived reaction to a certain substance, with symptoms ...

On its way to generating sales of $14 billion in just its seventh full year on the market, Sanofi and Regeneron’s Dupixent ...

Understanding the causes, symptoms, treatment options ... It is also known by other names such as nettle rash, hives, or wheals. These lesions usually last for a few hours but do not exceed ...

The FDA approved dupilumab for the treatment of patients 12 years and older with chronic spontaneous urticaria who remain ...

The following content is for informational purposes only. This article is not intended to be a substitute for profession ...

A doctor has shed some light on why itchy rashes sometimes mysteriously appear on the body - and what you need to do ...

The partners overcame an earlier rejection to win a seventh use for Dupixent, though some analysts are skeptical of its sales ...

Resubmission of the supplemental biologics license application provided more data on improvement in hives and itching in ...

Hives are similar to a medication rash ... In more severe cases of RA rash, a doctor may treat the rash directly. In these instances, a doctor may prescribe topical antibiotics or steroids ...

Marking the first approval in over a decade for this challenging condition, the FDA has approved dupilumab (Dupixent) to treat chronic spontaneous urticaria in patients 12 years and older whose hives ...

The FDA approved dupilumab (Dupixent) for chronic spontaneous urticaria (CSU) in patients 12 years and older, the first new ...